The WHO has added semaglutide and other GLP‑1 drugs to its 2025 Essential Medicines List, which means they could become cheaper and more widely available, especially in low‑ and middle‑income countries. This makes these powerful weight‑loss and blood‑sugar medicines more realistic for self‑experimenters, but you still need a prescription and should follow proper dosing to avoid misuse.
Zacharia. George S GS; Gongati. Sudharsan R SR; Kharel. Aayush A; Jacob. Anu A
Semaglutide, a weekly injectable (and oral) GLP‑1 drug best known for diabetes and weight loss, also helps heal fatty liver disease (MASH) by reducing liver inflammation and scarring. It’s now approved for non‑cirrhotic MASH with moderate‑to‑advanced fibrosis, but it can cause stomach upset, low blood sugar, and very rare pancreas or thyroid issues.
Malighetti. Maria E ME; Vescini. Fabio F; Carpentieri. Maria M; Altomari. Anna A; Turchi. Federica F...
In a real‑world study of 142 people with type‑2 diabetes, adding the pill form of semaglutide to their existing SGLT2‑inhibitor meds lowered blood sugar and helped many lose weight, with mostly mild stomach side effects.
Wilkinson. Thomas J TJ; Goldney. Jonathan J; Yates. Thomas T; Henson. Joseph J; Zaccardi. Francesco...
In people with type‑2 diabetes and chronic kidney disease, taking the weight‑loss drug semaglutide cuts the chances of kidney failure, heart attacks, strokes, and death compared with a neutral diabetes drug. The study used real‑world health records, so the results reflect everyday use, not just a tightly controlled trial.
Gonzalez. Frances F; Reid. Mark W MW; Garcia. Jaquelin Flores JF; Raymond. Jennifer K JK; Chao. Lily...
A small study of 24 teens and young adults with type‑1 diabetes and obesity found that taking a GLP‑1 drug (like semaglutide) for about a year led to big weight loss (about 9½ kg), lower BMI, and a big cut in how much insulin they needed, while also nudging blood‑sugar control a bit better. The main side‑effects were short‑lived stomach upset.
A big review of studies shows that drugs like semaglutide, already used for diabetes and weight loss, also cut down how much people drink and lower cravings, especially in folks who are overweight or have diabetes. The effect is strong enough that it could be added to a personal health plan, but you’d need a doctor’s prescription and monitoring.
Saha. Bibek B; Kamalumpundi. Vijayvardhan V; Codipilly. Don C DC
GLP‑1 drugs like semaglutide often cause stomach upset—up to 70% of users get nausea, vomiting, or diarrhea. Simple diet tweaks (smaller, frequent meals, plenty of water, and cutting out high‑fat or sugary foods) can ease these symptoms. Before an endoscopy, especially with long‑acting drugs, there’s a higher chance of leftover food in the stomach, so a short liquid diet or pausing the drug may help, while colonoscopy prep might work better if the drug is held temporarily.
Bhatti. Rahila R; Sadiya. Amena A; Mussa. Bashair M BM; Khan. Rawoof R; Abusnana. Salah S
In a real‑world clinic in Dubai, people with obesity who took the GLP‑1 drug semaglutide or the newer dual‑agonist tirzepatide lost a lot of weight and body fat over a year, with tirzepatide showing the biggest drop (about 22% of body weight) after 12 months. Both drugs also cut waist size, visceral fat, and improved blood sugar and liver numbers, while a supportive lifestyle plan helped keep muscle mass intact. Women tended to lose a bit more weight than men.
Mohamed Ali Elbashir. Roaa R; Elbashir. Azza A; Urimuke Basake. Robert R; Zakaria Ahmed Mohieldin. A...
A big review of 13 trials shows that GLP‑1 drugs like semaglutide can cut body weight by about 13% in people who are overweight but don’t have diabetes, while also lowering BMI, waist size and blood pressure. The effect is strong enough that people are 3‑15 times more likely to lose at least 5‑20% of their weight compared to not using the drug. Another GLP‑1 drug, tirzepatide, worked even better than semaglutide.
Ruseva. Aleksandrina A; Michalak. Wojciech W; Fabricatore. Anthony A; Hartaigh. Bríain Ó B...
In a real‑world US study, people who stayed on the weekly 1.7 mg or 2.4 mg dose of semaglutide for two years lost about 18 kg (roughly 17% of their body weight) and saw big improvements in blood pressure, blood sugar, cholesterol and triglycerides.
Osorio Manyari. Angel Alois AA; Armas Alvarez. Azucena Lirio AL; Osorio Manyari. Joel Davis JD; Onie...
A review of eight studies found that people who regain weight after bariatric surgery lose about 11% of their body weight when they take semaglutide (and about 14% with tirzepatide). This shows these drugs can be a practical tool for tackling post‑surgery weight rebound.
Purcell. Amanda R AR; Zhen. Xi May XM; Wong. Jencia J; Glastras. Sarah J SJ
Adding a GLP‑1 drug like semaglutide to insulin in adults with type‑1 diabetes who are overweight can help them lose about 4 kg, lower their A1c by roughly 0.25 %, and cut daily insulin by around 9 units, but it also raises the chance of low‑blood‑sugar episodes and causes stomach upset.
Hong. Alexander T AT; Lin. Forest F; Baxter. Sally S; Weinreb. Robert N RN
A large US study found that people with type‑2 diabetes who start tirzepatide (a dual GIP/GLP‑1 drug) have about half the risk of developing glaucoma or eye pressure problems compared to those who start regular GLP‑1 drugs like semaglutide. The benefit held up even in older adults and when patients were also taking metformin or insulin.
Noeth. M M; Van Zyl. F H FH; Hellig. J J; Conradie-Smit. M M; May. W W
The guideline says that semaglutide (2.4 mg once a week) is a top‑rated drug for losing weight in people with obesity (BMI ≥ 30 or ≥ 27 with health issues). It works best when combined with diet, exercise, and behavior therapy, and can also help keep weight off, delay diabetes, improve blood sugar in diabetics, and aid conditions like sleep apnea and fatty liver.
The paper says semaglutide, a GLP‑1 drug, not only lowers blood sugar but also helps you lose weight, protects your heart, kidneys and liver, and is safe enough to be used as a core treatment for people with obesity, diabetes, heart disease, kidney disease, or fatty liver. It recommends early screening and personalized dosing, fitting well into Saudi Arabia’s health plans, but the ideas apply to anyone looking to improve metabolic health.
Nakhleh. Afif A; Khazim. Khaled K; Shehadeh. Naim N
Adding the kidney drug finerenone to people with type‑2 diabetes who are already taking a SGLT2 inhibitor and a GLP‑1 peptide like semaglutide cuts urine protein (albumin) by about half, though it may slightly lower kidney filtration rate and raise potassium a bit.
Tchang. Beverly B; Broffman. Lauren L; Manalac. Raoul R; Chai. Sam S; Samonas. Nicholas N; Barnes. M...
A large real‑world study of 655 people who got semaglutide through telehealth showed they lost about 16% of their body weight on average, with side effects like nausea and constipation that matched what clinical trials have reported. Women were more likely to hit bigger weight‑loss milestones.
Niu. S S; Wang. C X CX; Zhao. Y B YB; Wu. D D; Yang. K L KL
A 12‑week course of semaglutide (starting at 0.25 mg then 0.5 mg weekly) in obese people with type‑2 diabetes and fatty liver cut weight, lowered blood sugar, reduced liver stiffness and inflammation, and shifted blood metabolites toward more beneficial fats and amino‑acid profiles.
Kamrul-Hasan. A B M ABM; Chatterjee. Subhankar S; Ashraf. Hamid H; Nagendra. Lakshmi L; Dutta. Deep...
A big real‑world analysis of over 118,000 people with type‑2 diabetes shows that tirzepatide cuts the chances of heart attacks, heart‑failure hospitalizations, strokes, major cardiovascular events and even death compared to usual care, and it does a bit better than semaglutide for strokes and overall cardiovascular risk. The drug didn’t change the risk of sudden cardiac death. These findings suggest tirzepatide could be a powerful tool for people looking to improve heart health while managing diabetes or weight.
Noronha. Jarvis C JC; Van Gaal. Luc F LF; Neeland. Ian J IJ; Fitch. Angela A; Pfeiffer. Andreas Fh A...
The article gives clear, doable tips for people using semaglutide or similar GLP‑1 drugs: eat enough protein (over 1.2 g per kg body weight each day) spread over all meals, add regular cardio and strength training, and follow simple tricks to lessen nausea, diarrhea, constipation, gallstones, and reflux. These steps help keep muscle, improve weight loss, and make the drug easier to stick with.